Guías de práctica clínica de la SERVmanejo de las oclusiones venosas de la retina

Referencias bibliográficas

• Hayreh, S.S.. (2005). Prevalent misconceptions about acute retinal vascular occlusive disorders. Prog Retin Eye Res.. 24. 493-519
• Scott, I.U., Blodi, B.A., Ip, M.S., Vanveldhuisen, P.C., Oden, N.L., Chan, C.K.. (2009). Score Study report 2: Interobserver agreement between investigador and Redding center classification of retinal vein occlusion type. Opthalmology.. 116. 756
• Haymore, J.G., Mejico, L.J. (2009). Retinal vascular occlusion syndromes. International Ophthalmology Clinics.. 49. 63-79
• Green, W.R., Chan, C.C., Hutchins, G.M., Terry, M. (1981). Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases. Trans Am Ophthalmol Soc.. 79. 371-422
• Sperduto, R.D., Hiller, R., Chew, E., Seigel, D., Blair, N., Burton, T.C.. (1998). Risk factors for hemiretinal vein occlusion: comparison with risk factors for central and branch retinal vein occlusion: the eye disease case-control study. Ophthalmology.. 105. 765
• (1996). Risk factors for central retinal vein occlusion. Arch Ophthalmol.. 114. 545
• Williamson, T.H., Rumley, A., Lowe, G.D. (1996). Blood viscosity, coagulation, and activated protein C resistance in central retinal vein occlusion: a population controlled study. Br J Ophthalmol.. 80. 203
• Avashia, J.H., Fath, D.F. (1989). Bilateral central retinal vein oclussion in Waldenstrom's macroglobulinemia. J Am Optom Assoc.. 60. 657
• Ehlers, N. (1999). Thrombophilia: a feature of importance in retinal vein thrombosis?. Acta Ophthalmol Scand.. 77. 619
• Cahill, M., Karabatzaki, M., Meleady, R., Refsum, H., Ueland, P., Shields, D.. (2000). Raised plasma homocysteine as a risk factor for retinal vascular occlusive disease. Br J Ophthalmol.. 84. 154
• Vine, A.K. (2000). Hyperhomocysteinemia: a risk factor for central retinal vein occlusion. Am J Ophthalmol.. 129. 640
• Castañón, C., Amigo, M.C., Banales, J.L., Nava, A., Reyes, P.A. (1995). Ocular vaso-occlusive disease in primary antiphospholipid syndrome. Ophthalmology.. 102. 256
• Kirwan, J.F., Tsaloumas, M.D., Vinall, H., Prior, P., Kritzinger, E.E., Dodson, P.M. (1997). Sex hormone preparations and retinal vein occlusion. Eye.. 11. 53
• Retinal Vein Occlusion (RVO) Interim Guidelines.
• Hayreh, S.S., Rojas, P., Podhajsky Montague, ,P, Woolson, RF. (1983). Ocular neovascularization in retinal vascular occlusion -III: Incidence of ocular neovascularization huir retinal vein occlusion. Ophthalmology.. 90. 488-506
• Hayreh, S.S., Hayreh, M.S. (1980). Hemi-central retinal vein occlusion: Pathogenesis, clinical features, and natural history. Arch Ophthalmol.. 98. 1600
• Magargal, L.E., Donoso, L.A., Sanborn, G.E. (1982). Retinal ischemia and risk of neovascularization following central retinal vein obstruction. Ophthalmology.. 89. 1241
• Minturn, J., Brown, G.C. (1986). Progression of nonischemic central retinal vein obstruction to the isqchemic variante. Ophthalmology.. 93. 1158
• (1997). Natural history and clinical management of central retinal vein occlusion. Arch Ophthalmol.. 115. 486
• (1995). A randomized clinical trial of early panretinal photocoagulation for ischemic central vein occlusion: The Central Retinal Vein Occlusion Study Group N Report. Ophthalmology.. 102. 1434
• (1986). Argon laser scatter photocoagulation for prevention of neovascularisation and vitreous hemorrhage in branch vein occlusion: A randomized clinical trial. Arch Ophthalmol.. 104. 34-41
• Hayreh, S.S., Zimmerman, M.B., Podhajsky, P. (1994). Incidence of various types od retinal vein occlusion and their recurrence and demographic characteristics. Am J Ophthalmol.. 117. 429
• Catier, A., Tadayoni, R., Paques, M., Erginay, A., Haouchine, B., Gaudric, A.. (2005). Characterization of macular edema from various etiologies by optical coherence tomography. Am J Ophthalmol.. 140. 200
• Panozzo, G., Parolini, B., Gusson, E., Mercanti, A., Pinackatt, S., Bertoldo, G.. (2004). Diabetic macular edema: an OCT-based classification. Semin Ophthalmol.. 19. 13-20
• Laatikainen, L. (1983). A prospective follow-up study of panretinal photocagulation in preventing neovascular glaucoma following ischaemic central retinal vein occlusion. Graefe's Arch Clin Exp Ophthalmol.. 220. 236
• Davidorf, F.H., Mouser, J.G., Derick, R.J. (2006). Rapid improvement of rubeosis iridis from a single bevacizumab (Avastin) injection. Retina.. 26. 354
• Beutel, J., Peters, S., Lüke, M., Aisenbrey, S., Szurman, P., Spitzer, M.S.. (2008). Bevacizumab as adjuvant for neovascular glaucoma. Acta Ophthalmol..
• Cornish, K.S., Ramamurthi, S., Saidkasimova, S., Ramaesh, K. (2009). Intravitreal bevacizumab and augmented trabeculectomy for neovascular glaucoma in young diabetic patients. Eye.. 23. 979
• (1995). Evaluation of grid patternphotocoagulation for macular edema in central vein occlusion. Ophthalmology.. 102. 1425
• Greenberg, P.B., Martidis, A., Rogers, A.H., Duker, J.S., Reichel, E. (2002). Intravitreal triamcinolone acetonide for macular edema due to central retinal vein occlusion. Br J Ophthalmol.. 86. 247
• Karacorlu, M., Ozdemir, H., Karacorlu, S. (2004). Intravitreal triamcinolone acetonide for the treatment of central retinal vein occlusion in young patientes. Retina.. 24. 324
• Williamson, T.H., O´Donell, A. (2005). Intravitreal triamcinolone for cystoid macular edma in nonischemic central retinal vein occlusion. Am J Ophthalmol.. 139. 860
• Gregory, N.Z., Rosenfeld, P.J., Puliafito, C.A., Flynn, H.W., Lee, J.E., Mavrofrides, E.C.. (2006). One year safety and efficacy of intravitreal triamcinolone acetónide for the management of macular edema secondary to central retinal vein occlusion. Retina.. 26. 889
• Gewaily, D, Greenberg, PB. (2009). Intravitreal steroids versus observation for macular edema secondary to central retinal vein occlusion. Cochrane Database Syst Rev.. 1. 007324
• Roth, D.B., Cukras, C., Radhakrishnan, R., Feuer, W.J., Yarian, D.L., Green, S.N.. (2008). Intravitreal triamcinolone acetonide injections in the treatment of retinal vein occlusions. Ophthalmic Surg Lasers Imaging.. 39. 446
• Wang, L., Song, H. (2009). Effects of repeated injection of intravitreal triamcinolone on macular oedema in central retinal vein occlusion. Acta Ophthalmol.. 87. 285
• Scott, I.U., Vanveldhuisen, P.C., Oden, N.L., Ip, M.S., Blodi, B.A., Jumper, J.M.. (2009). SCORE Study Report 1: Baseline Associations between Central Retinal Thickness and Visual Acuity in Patients with Retinal Vein Occlusion. Ophthalmology.. 116. 504
• The Standard Care vs. COrticosteroid for REtinal Vein Occlusion (SCORE) Study: Clinicaltrials.gov Identifier NCT00105027.
• Ip, M.S., Scott, I.U., VanVeldhuisen, P.C., Oden, N.L., Blodi, B.A., Fisher, M.. (2009). A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5. Arch Ophthalmol.. 127. 1101
• A Study of the Safety and Efficacy, of a New Treatment for Macular Edema Resulting From Retinal Vein Occlusion ClinicalTrials.gov Identifier: NCT00168324 and NCT00168298.
• Spaide, R.F., Chang, L.K., Klancnik, J.M., Yannuzzi, L.A., Sorenson, J., Slakter, J.S.. (2009). Prospective study of intravitreal ranibizumab as a treatment for decreased visual acuity secondary to central retinal vein occlusion. Am J Ophthalmol.. 147. 298-306
• Campochiaro, P.A., Hafiz, G., Shah, S.M., Nguyen, Q.D., Ying, H., Do, D.V.. (2008). Ranibizumab for macular edema due to retinal vein occlusions: implication of VEGF as a critical stimulator. Mol Ther.. 16. 791
• Pieramici, D.J., Rabena, M., Castellarin, A.A., Nasir, M., See, R., Norton, T.. (2008). Ranibizumab for the treatment of macular edema associated with perfused central retinal vein occlusions. Ophthalmology.. 115. 47-54
• Beutel, J., Ziemssen, F., Lüke, M., Partsch, M., Bartz-Schmidt, K.U. (2010). The Bevacizumab Study Group. Intravitreal bevacizumab treatment of macular edema in central retinal vein occlusion: one-year results. Int Ophthalmol.. 30. 15-22
• Prager, F., Michels, S., Kriechbaum, K., Georgopoulos, M., Funk, M., Geitzenauer, W.. (2009). Intravitreal bevacizumab (Avastin) for macular oedema secondary to retinal vein occlusion: 12-month results of a prospective clinical trial. Br J Ophthalmol.. 93. 452
• Ferrara, D.C., Koizumi, H., Spaide, R.F. (2007). Early bevacizumab treatment of central retinal vein occlusion. Am J Ophthalmol.. 144. 864
• A Study of the Efficacy and Safety of Ranibizumab Injection in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion (CRUISE): Clinicaltrials gov Identifier NCT00485836.
• McAllister, I.L., Douglas, J.P., Constable, I.J., Yu, D.Y. (1998). Laser-induced chorioretinal venous anastomosis for nonischemic central retinal vein occlusion: evaluation of the complications and their risk factors. Am J Ophthalmol.. 126. 219
• Eccarius, S.G., Moran, M.J., Slingby, J.G. (1996). Choroidal neovascular membrane after laser-induced chorioretinal anastomosis. Am J Ophthalmol.. 122. 590
• Luttrull, J.K. (1997). Epiretinal membrane and traction retinal detachment complicating laser-induced chorioretinal venous anastomosis. Am J Ophthalmol.. 123. 698
• Browning, D.J., Rotberg, M.H. (1996). Vitreous hemorrhage complicating laser-induced chorioretinal anastomosis for central retinal vein occlusion. Am J Ophthalmol.. 122. 588
• (1986). Argon laser scatter photocoagulation for prevention of neovascularization and vitreous hemorrhage in branch vein occlusion: A randomized clinical trial. Arch Ophthalmol.. 104. 34-41
• Shilling, J.S., Kohner, E.M. (1976). New vessel formation in retinal branch vein occlusion. Br J Ophthalmol.. 60. 810
• Hayreh, S.S., Rubenstein, L., Podhajsky, P. (1993). Argon laser scatter photocoagulation in treatment of branch retinal vein occlusion: A prospective clinical trial. Ophthalmologica.. 206. 1-14
• (1984). Argon laser photocoagulation for macular edema in branch vein occlusion. Am J Ophthalmol.. 98. 271
• Shilling, J.S., Jones, C.A. (1984). Retinal branch vein occlusion: A study of argon laser photocoagulation in the treatment of macular oedema. Br J Ophthalmol.. 68. 196
• Cakir, M., Dogan, M., Bayraktar, Z., Bayraktar, S., Acar, N., Altan, T.. (2008). Efficacy of intravitreal triamcinolone for the treatment of macular edema secondary to branch retinal vein occlusion in eyes with or without grid laser photocoagulation. Retina.. 28. 465
• Bearelly, S., Cooney, M.J., Stinnett, S., Fekrat, S. (2006). Intravitreal triamcinolone for cystoid macular edema related to branch retinal vein occlusion. Ann Ophthalmol (Skokie).. 38. 317
• Oh, J.Y., Seo, J.H., Ahn, J.K., Heo, J.W., Chung, H. (2007). Early versus late intravitreal triamcinolone acetonide for macular edema associated with branch retinal vein occlusion. Korean J Ophthalmol.. 21. 18-20
• Scott, I.U., Ip, M.S., VanVeldhuisen, P.C., Oden, N.L., Blodi, B.A., Fisher, M.. (2009). A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular Edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6. Arch Ophthalmol.. 127. 1115
• Kawaji, T., Takano, A., Inomata, Y., Sagara, N., Iwao, K., Inatani, M.. (2008). Trans-Tenon's retrobulbar triamcinolone acetonide injection for macular oedema related to branch retinal vein occlusion. Br J Ophthalmol.. 92. 81
• Hayashi, K., Hayashi, H. (2005). Intravitreal versus retrobulbar injections of triamcinolone for macular edema associated with branch retinal vein occlusion. Am J Ophthalmol.. 139. 972
• Russo, V., Barone, A., Conte, E., Prascina, F., Stella, A., Noci, N.D. (2009). Bevacizumab compared with macular laser grid photocoagulation for cystoid macular edema in branch retinal vein occlusion. Retina.. 29. 511
• Iturralde, D., Spaide, R.F., Meyerle, C.B., Klancnik, J.M., Yannuzzi, L.A., Fisher, Y.L.. (2006). Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study. Retina.. 26. 279
• Rabena, M.D., Pieramici, D.J., Castellarin, A.A., Nasir, M.A., Avery, R.L. (2007). Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusion. Retina.. 27. 419
• Rensch, F., Jonas, J.B., Spandau, U.H. (2008). Early Intravitreal Bevacizumab for Non-Ischaemic Branch Retinal Vein Occlusion. Ophthalmologica.. 223. 124
• A Study of the Efficacy and Safety of Ranibizumab Injection in Patients With Macular Edema Secondary to Branch Retinal Vein Occlusion (BRAVO): Clinicaltrials gov Identifier NCT00486018.
• Hayreh, S.S., Rojas, P., Podhajsky, P., Montague, P., Woolson, RF. (1983). Ocular neovascularisation with retinal vascular occlusion- III: Incidence of ocular neovascularisation with retinal vein occlusion. Ophthalmology.. 90. 488-506
• Oprencak, E.M., Bruce, R.A., Lomeo, M.D., Ridenour, C.D., Letson, A.D., Rehmar, A.J. (2001). Radial optic neurotomy for central retinal vein occlusion. Retina.. 21. 408
• García-Arumi, J., Boixadera, A., Martínez-Castillo, V., Castillo, R., Dou, A., Corcostegui, B. (2003). Chorioretinal anastomosis: After radial optic reurotomy for central retinal vein occlusion. Arch Ophthalmol.. 121. 1385
• Opemcak, E.M., Rehmar, A.J., Ridenour, C.D., Kurtz, D.E. (2006). Radial optic neurotomy for central retinal vein occlusion 117 consecutive cases. Retina.. 26. 297-305
• Opremcak, E.M., Rehmar, A.J., Ridenour, C.D., Kurtz, D.E., Borkowski, L.M. (2006). Radial optic neurotomy with adjunctive intraocular triamcinolone for central retinal vein occlusion. Retina.. 26. 306
• Shahid, H., Hossain, P., Amokau, W.M. (2006). The management of retinal vein occlusion is interventional ophthalmology the way forward?. Br J Ophthalmol.. 90. 627
• Binder, S., Aggemann, T., Brunner, S. (2007). Long-term affects of radial optic neurotomy for central retinal vein occlusion consecutive interventional cases series. Graefes Arch Clin Exp Ophthalmol.. 245. 1447
• Callizo, J, Kroll, P., Mennel, S., Schmidt, J.C., Meyer, CH. (2009). Radial optic reurotomy for central retinal vein occlusion: long. term retinal perfusion outcome. Ophthalmologica.. 223. 313
• Beer, P.M., Bakri, S.J., Singh, R.L., Liu, W., Peters, G.B., Miller, M. (2003). Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injeccition. Ophthalmology.. 110. 681
• Stefansson, E., Novack, R.L., Hatchell, D.L. (1990). Vitrectomy prevents retinal hypoxia in branch retinal vein occlusion. Invest Ophthalmol Vis Sci.. 31. 284
• Lewis, H., Abrams, G.W., Blumenkranz, M.S.. (1992). Vitrectomy for diabetic retinopathy. Am J Ophthalmol.. 99. 753
• Tachi, N., Ogino, N. (1996). Vitrectomy for diffuse macular edema in cases o diabetic retinopathy. Am J Ophthalmol.. 122. 258
• Sebag, J., Balazs, E.A. (1984). Pathogenesis of cystoid macular edema: an anatomic consideration of vitreoretinal adhesions. Surv Ophthalmol.. 28. 493
• (1984). Argon laser photocoagulation for macular edema in branch vein occlusion. Am J Ophthalmol.. 98. 271
• Osterloh, M.D., Charles, S. (1988). Surgical decompression of branch retinal vein occlusion. Arch of Ophthalmol.. 106. 1469
• Opremcak, E.M., Bruce, R.A. (1999). Surgical decompression of branch retinal vein occlusion via arteriovenous crossing sheathotomy: a prospective review of 15 cases. Retina.. 19. 1-5
• Mester, U., Dillinger, P. (2002). Vitrectomy with arteriovenous descompression and internal limiting membrane dissection in branch retinal vein occlusion. Retina.. 22. 740
• Kumagai, K., Furukawa, M., Ogino, N., Uemura, A., Larson, E. (2007). Long-term outcomes of vitrectomy with or without arteriovenous sheathotomy in branch retinal vein occlusion. Retina.. 27. 49-54
• Figueroa, M.S., Torres, R., Álvarez, M.T. (2004). Comparative study of vitrectomy with and without vein decompression for branch retinal vein occlusion: a pilot study. Eur J Ophthalmol.. 14. 40
• Lahey, J.M., Fong, D.S., Kearney, J. (1999). Intravitreal tissue plasminogen activator for acute central retinal vein occlusion. Ophthalmic Surg Lasers.. 30. 427
• Elman, M. (1996). Thrombolytic therapy for central retinal vein occlusion: results of a pilot study. Tr Am Ophth Soc.. 471-504
• Glacet-Bernard, A., Kuhn, D., Vine, A.K., Oubraham, H., Coscas, G., Soubrane, G. (2000). Treatment of recent onset central retinal vein occlusion with intravitreal issue plasminogen activator: a pilot study. Br J Ophthalmol.. 84. 609
• Ghazi, N.G., Noureddine, B., Haddad, R.S., Jurdi, F.A., Bashshur, Z.F. (2003). Intravitreal tissue plasminogen activator in the management of central retinal vein occlusion. Retina.. 23. 780
• Loren, L.J., Frade, G., Torrado, M.C., Navarro, JL. (1989). Thrombus age and tissue plasminogen mediated thrombolysis in rats. Throm Res.. 56. 67-76
• Tsaloumas, M.D., Kirwan, J., Vinall, H., O'Leary, M., Prior, P., Kritzinger, E.E.. (2000). Nine year follow up study of morbidity and mortality in retinal vein occlusion. Eye.. 14. 821